rs145518215
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_ModerateBP6_Moderate
The NM_024915.4(GRHL2):c.373T>G(p.Ser125Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000372 in 1,613,942 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_024915.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant nonsyndromic hearing loss 28Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
- nonsyndromic genetic hearing lossInheritance: AD Classification: STRONG Submitted by: ClinGen
- posterior polymorphous corneal dystrophyInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, G2P
- nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndromeInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital fibrosis of extraocular musclesInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GRHL2 | NM_024915.4 | c.373T>G | p.Ser125Ala | missense_variant | Exon 4 of 16 | ENST00000646743.1 | NP_079191.2 | |
| GRHL2 | NM_001330593.2 | c.325T>G | p.Ser109Ala | missense_variant | Exon 4 of 16 | NP_001317522.1 | ||
| GRHL2 | NM_001440448.1 | c.325T>G | p.Ser109Ala | missense_variant | Exon 4 of 16 | NP_001427377.1 | ||
| GRHL2 | NM_001440447.1 | c.373T>G | p.Ser125Ala | missense_variant | Exon 4 of 16 | NP_001427376.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152058Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251454 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461884Hom.: 0 Cov.: 33 AF XY: 0.00000275 AC XY: 2AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74268 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
Ser125Ala in Exon 4 of GRHL2: This variant has been identified in 0.02% (1/4406) of African American chromosomes in a broad population by the NHLBI Exome sequen cing project (http://evs.gs.washington.edu/EVS/; dbSNP rs145518215); however, th is frequency is not high enough to rule out a pathogenic role. Computational ana lyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, an d SIFT) suggest that the Ser125Ala variant is not likely to impact the protein, in part due to the fact that the Ser125 residue is not conserved in mammals (thr ee have a cysteine despite nearby conservation). These data, combined with ident ification of this variant in a family without dominant hearing loss, the known i nheritance pattern for pathogenic variants in this gene, suggests that this vari ant is more likely benign. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at